Review



cell line ipsc origin human additional origin info  (Jackson Laboratory)

 
  • Logo
  • About
  • News
  • Press Release
  • Team
  • Advisors
  • Partners
  • Contact
  • Bioz Stars
  • Bioz vStars
  • 86

    Structured Review

    Jackson Laboratory cell line ipsc origin human additional origin info
    Cell Line Ipsc Origin Human Additional Origin Info, supplied by Jackson Laboratory, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/cell+line+ipsc+origin+human+additional+origin+info/ipsc+line/pm41265249-13-35-59
    Average 86 stars, based on 1 article reviews
    cell line ipsc origin human additional origin info - by Bioz Stars, 2026-10
    86/100 stars

    Images

    Related Articles

    Virus:

    Article Title: CRISPR/Cas9-mediated editing of XPA in induced pluripotent stem cells: A model for investigating Xeroderma Pigmentosum and NER dysfunction.
    Article Snippet: .. Resource table Unique stem cell line identifier WTSIi018-B-30 Alternative name(s) of stem cell line DU434 Institution IUF Leibniz Institute for Environmental Medicine Contact information of the reported cell line distributor Jean Krutmann; jean.krutmann@IUFduesseldorf.de Type of cell line iPSC Origin Human Additional origin info (applicable for human ESC or iPSC) Age: 55–59 Sex: male Ethnicity: Caucasian; British Cell Source KOLF2.1J, The Jackson Laboratory https://www.jax.org/jax-mice-and-servic es/ipsc Method of reprogramming Sendai Virus Clonality Monoclonal Evidence of the reprogramming transgene loss (including genomic copy if applicable) PCR The cell culture system used iPSCs cultured on geltrex-coated plates and passaged using Accutase Type of the Genetic Modification Patient-specific point mutation Associated disease Xeroderma Pigmentosum (continued on next column) (continued ) Gene/locus XPA homozygous 9q22.33 exon 3 point mutation NM_000380.4(XPA):c.323G>T (p. Cys108Phe) Method of modification / usercustomisable nuclease (UCN) used, the resource used for design optimisation CRISPR/Cas9 User-customisable nuclease (UCN) delivery method Plasmid transfection All double-stranded DNA genetic material molecules introduced into the cells PX458 (Addgene #48138) Analysis of the nuclease-targeted allele status Illumina Deep Sequencing and homozygosity confirmed through ONT Sequencing Method of the off-target nuclease activity prediction and surveillance In-silico Descriptive name of the transgene Eukaryotic selective agent resistance cassettes (including inducible, gene/ cell type-specific) (continued on next page) * Corresponding authors at: Environmental Adaptation and Cellular Resilience Laboratory, IUF-Leibniz Research Institute for Environmental Medicine, Düsseldorf, Germany (A. Rossi) and Environmentally-Induced Skin Aging Group, IUF-Leibniz Research Institute for Environmental Medicine, Düsseldorf, Germany (J. Krutmann). ..

    Polymerase Chain Reaction:

    Article Title: CRISPR/Cas9-mediated editing of XPA in induced pluripotent stem cells: A model for investigating Xeroderma Pigmentosum and NER dysfunction.
    Article Snippet: .. Resource table Unique stem cell line identifier WTSIi018-B-30 Alternative name(s) of stem cell line DU434 Institution IUF Leibniz Institute for Environmental Medicine Contact information of the reported cell line distributor Jean Krutmann; jean.krutmann@IUFduesseldorf.de Type of cell line iPSC Origin Human Additional origin info (applicable for human ESC or iPSC) Age: 55–59 Sex: male Ethnicity: Caucasian; British Cell Source KOLF2.1J, The Jackson Laboratory https://www.jax.org/jax-mice-and-servic es/ipsc Method of reprogramming Sendai Virus Clonality Monoclonal Evidence of the reprogramming transgene loss (including genomic copy if applicable) PCR The cell culture system used iPSCs cultured on geltrex-coated plates and passaged using Accutase Type of the Genetic Modification Patient-specific point mutation Associated disease Xeroderma Pigmentosum (continued on next column) (continued ) Gene/locus XPA homozygous 9q22.33 exon 3 point mutation NM_000380.4(XPA):c.323G>T (p. Cys108Phe) Method of modification / usercustomisable nuclease (UCN) used, the resource used for design optimisation CRISPR/Cas9 User-customisable nuclease (UCN) delivery method Plasmid transfection All double-stranded DNA genetic material molecules introduced into the cells PX458 (Addgene #48138) Analysis of the nuclease-targeted allele status Illumina Deep Sequencing and homozygosity confirmed through ONT Sequencing Method of the off-target nuclease activity prediction and surveillance In-silico Descriptive name of the transgene Eukaryotic selective agent resistance cassettes (including inducible, gene/ cell type-specific) (continued on next page) * Corresponding authors at: Environmental Adaptation and Cellular Resilience Laboratory, IUF-Leibniz Research Institute for Environmental Medicine, Düsseldorf, Germany (A. Rossi) and Environmentally-Induced Skin Aging Group, IUF-Leibniz Research Institute for Environmental Medicine, Düsseldorf, Germany (J. Krutmann). ..

    Cell Culture:

    Article Title: CRISPR/Cas9-mediated editing of XPA in induced pluripotent stem cells: A model for investigating Xeroderma Pigmentosum and NER dysfunction.
    Article Snippet: .. Resource table Unique stem cell line identifier WTSIi018-B-30 Alternative name(s) of stem cell line DU434 Institution IUF Leibniz Institute for Environmental Medicine Contact information of the reported cell line distributor Jean Krutmann; jean.krutmann@IUFduesseldorf.de Type of cell line iPSC Origin Human Additional origin info (applicable for human ESC or iPSC) Age: 55–59 Sex: male Ethnicity: Caucasian; British Cell Source KOLF2.1J, The Jackson Laboratory https://www.jax.org/jax-mice-and-servic es/ipsc Method of reprogramming Sendai Virus Clonality Monoclonal Evidence of the reprogramming transgene loss (including genomic copy if applicable) PCR The cell culture system used iPSCs cultured on geltrex-coated plates and passaged using Accutase Type of the Genetic Modification Patient-specific point mutation Associated disease Xeroderma Pigmentosum (continued on next column) (continued ) Gene/locus XPA homozygous 9q22.33 exon 3 point mutation NM_000380.4(XPA):c.323G>T (p. Cys108Phe) Method of modification / usercustomisable nuclease (UCN) used, the resource used for design optimisation CRISPR/Cas9 User-customisable nuclease (UCN) delivery method Plasmid transfection All double-stranded DNA genetic material molecules introduced into the cells PX458 (Addgene #48138) Analysis of the nuclease-targeted allele status Illumina Deep Sequencing and homozygosity confirmed through ONT Sequencing Method of the off-target nuclease activity prediction and surveillance In-silico Descriptive name of the transgene Eukaryotic selective agent resistance cassettes (including inducible, gene/ cell type-specific) (continued on next page) * Corresponding authors at: Environmental Adaptation and Cellular Resilience Laboratory, IUF-Leibniz Research Institute for Environmental Medicine, Düsseldorf, Germany (A. Rossi) and Environmentally-Induced Skin Aging Group, IUF-Leibniz Research Institute for Environmental Medicine, Düsseldorf, Germany (J. Krutmann). ..

    Modification:

    Article Title: CRISPR/Cas9-mediated editing of XPA in induced pluripotent stem cells: A model for investigating Xeroderma Pigmentosum and NER dysfunction.
    Article Snippet: .. Resource table Unique stem cell line identifier WTSIi018-B-30 Alternative name(s) of stem cell line DU434 Institution IUF Leibniz Institute for Environmental Medicine Contact information of the reported cell line distributor Jean Krutmann; jean.krutmann@IUFduesseldorf.de Type of cell line iPSC Origin Human Additional origin info (applicable for human ESC or iPSC) Age: 55–59 Sex: male Ethnicity: Caucasian; British Cell Source KOLF2.1J, The Jackson Laboratory https://www.jax.org/jax-mice-and-servic es/ipsc Method of reprogramming Sendai Virus Clonality Monoclonal Evidence of the reprogramming transgene loss (including genomic copy if applicable) PCR The cell culture system used iPSCs cultured on geltrex-coated plates and passaged using Accutase Type of the Genetic Modification Patient-specific point mutation Associated disease Xeroderma Pigmentosum (continued on next column) (continued ) Gene/locus XPA homozygous 9q22.33 exon 3 point mutation NM_000380.4(XPA):c.323G>T (p. Cys108Phe) Method of modification / usercustomisable nuclease (UCN) used, the resource used for design optimisation CRISPR/Cas9 User-customisable nuclease (UCN) delivery method Plasmid transfection All double-stranded DNA genetic material molecules introduced into the cells PX458 (Addgene #48138) Analysis of the nuclease-targeted allele status Illumina Deep Sequencing and homozygosity confirmed through ONT Sequencing Method of the off-target nuclease activity prediction and surveillance In-silico Descriptive name of the transgene Eukaryotic selective agent resistance cassettes (including inducible, gene/ cell type-specific) (continued on next page) * Corresponding authors at: Environmental Adaptation and Cellular Resilience Laboratory, IUF-Leibniz Research Institute for Environmental Medicine, Düsseldorf, Germany (A. Rossi) and Environmentally-Induced Skin Aging Group, IUF-Leibniz Research Institute for Environmental Medicine, Düsseldorf, Germany (J. Krutmann). ..

    Mutagenesis:

    Article Title: CRISPR/Cas9-mediated editing of XPA in induced pluripotent stem cells: A model for investigating Xeroderma Pigmentosum and NER dysfunction.
    Article Snippet: .. Resource table Unique stem cell line identifier WTSIi018-B-30 Alternative name(s) of stem cell line DU434 Institution IUF Leibniz Institute for Environmental Medicine Contact information of the reported cell line distributor Jean Krutmann; jean.krutmann@IUFduesseldorf.de Type of cell line iPSC Origin Human Additional origin info (applicable for human ESC or iPSC) Age: 55–59 Sex: male Ethnicity: Caucasian; British Cell Source KOLF2.1J, The Jackson Laboratory https://www.jax.org/jax-mice-and-servic es/ipsc Method of reprogramming Sendai Virus Clonality Monoclonal Evidence of the reprogramming transgene loss (including genomic copy if applicable) PCR The cell culture system used iPSCs cultured on geltrex-coated plates and passaged using Accutase Type of the Genetic Modification Patient-specific point mutation Associated disease Xeroderma Pigmentosum (continued on next column) (continued ) Gene/locus XPA homozygous 9q22.33 exon 3 point mutation NM_000380.4(XPA):c.323G>T (p. Cys108Phe) Method of modification / usercustomisable nuclease (UCN) used, the resource used for design optimisation CRISPR/Cas9 User-customisable nuclease (UCN) delivery method Plasmid transfection All double-stranded DNA genetic material molecules introduced into the cells PX458 (Addgene #48138) Analysis of the nuclease-targeted allele status Illumina Deep Sequencing and homozygosity confirmed through ONT Sequencing Method of the off-target nuclease activity prediction and surveillance In-silico Descriptive name of the transgene Eukaryotic selective agent resistance cassettes (including inducible, gene/ cell type-specific) (continued on next page) * Corresponding authors at: Environmental Adaptation and Cellular Resilience Laboratory, IUF-Leibniz Research Institute for Environmental Medicine, Düsseldorf, Germany (A. Rossi) and Environmentally-Induced Skin Aging Group, IUF-Leibniz Research Institute for Environmental Medicine, Düsseldorf, Germany (J. Krutmann). ..

    CRISPR:

    Article Title: CRISPR/Cas9-mediated editing of XPA in induced pluripotent stem cells: A model for investigating Xeroderma Pigmentosum and NER dysfunction.
    Article Snippet: .. Resource table Unique stem cell line identifier WTSIi018-B-30 Alternative name(s) of stem cell line DU434 Institution IUF Leibniz Institute for Environmental Medicine Contact information of the reported cell line distributor Jean Krutmann; jean.krutmann@IUFduesseldorf.de Type of cell line iPSC Origin Human Additional origin info (applicable for human ESC or iPSC) Age: 55–59 Sex: male Ethnicity: Caucasian; British Cell Source KOLF2.1J, The Jackson Laboratory https://www.jax.org/jax-mice-and-servic es/ipsc Method of reprogramming Sendai Virus Clonality Monoclonal Evidence of the reprogramming transgene loss (including genomic copy if applicable) PCR The cell culture system used iPSCs cultured on geltrex-coated plates and passaged using Accutase Type of the Genetic Modification Patient-specific point mutation Associated disease Xeroderma Pigmentosum (continued on next column) (continued ) Gene/locus XPA homozygous 9q22.33 exon 3 point mutation NM_000380.4(XPA):c.323G>T (p. Cys108Phe) Method of modification / usercustomisable nuclease (UCN) used, the resource used for design optimisation CRISPR/Cas9 User-customisable nuclease (UCN) delivery method Plasmid transfection All double-stranded DNA genetic material molecules introduced into the cells PX458 (Addgene #48138) Analysis of the nuclease-targeted allele status Illumina Deep Sequencing and homozygosity confirmed through ONT Sequencing Method of the off-target nuclease activity prediction and surveillance In-silico Descriptive name of the transgene Eukaryotic selective agent resistance cassettes (including inducible, gene/ cell type-specific) (continued on next page) * Corresponding authors at: Environmental Adaptation and Cellular Resilience Laboratory, IUF-Leibniz Research Institute for Environmental Medicine, Düsseldorf, Germany (A. Rossi) and Environmentally-Induced Skin Aging Group, IUF-Leibniz Research Institute for Environmental Medicine, Düsseldorf, Germany (J. Krutmann). ..

    Plasmid Preparation:

    Article Title: CRISPR/Cas9-mediated editing of XPA in induced pluripotent stem cells: A model for investigating Xeroderma Pigmentosum and NER dysfunction.
    Article Snippet: .. Resource table Unique stem cell line identifier WTSIi018-B-30 Alternative name(s) of stem cell line DU434 Institution IUF Leibniz Institute for Environmental Medicine Contact information of the reported cell line distributor Jean Krutmann; jean.krutmann@IUFduesseldorf.de Type of cell line iPSC Origin Human Additional origin info (applicable for human ESC or iPSC) Age: 55–59 Sex: male Ethnicity: Caucasian; British Cell Source KOLF2.1J, The Jackson Laboratory https://www.jax.org/jax-mice-and-servic es/ipsc Method of reprogramming Sendai Virus Clonality Monoclonal Evidence of the reprogramming transgene loss (including genomic copy if applicable) PCR The cell culture system used iPSCs cultured on geltrex-coated plates and passaged using Accutase Type of the Genetic Modification Patient-specific point mutation Associated disease Xeroderma Pigmentosum (continued on next column) (continued ) Gene/locus XPA homozygous 9q22.33 exon 3 point mutation NM_000380.4(XPA):c.323G>T (p. Cys108Phe) Method of modification / usercustomisable nuclease (UCN) used, the resource used for design optimisation CRISPR/Cas9 User-customisable nuclease (UCN) delivery method Plasmid transfection All double-stranded DNA genetic material molecules introduced into the cells PX458 (Addgene #48138) Analysis of the nuclease-targeted allele status Illumina Deep Sequencing and homozygosity confirmed through ONT Sequencing Method of the off-target nuclease activity prediction and surveillance In-silico Descriptive name of the transgene Eukaryotic selective agent resistance cassettes (including inducible, gene/ cell type-specific) (continued on next page) * Corresponding authors at: Environmental Adaptation and Cellular Resilience Laboratory, IUF-Leibniz Research Institute for Environmental Medicine, Düsseldorf, Germany (A. Rossi) and Environmentally-Induced Skin Aging Group, IUF-Leibniz Research Institute for Environmental Medicine, Düsseldorf, Germany (J. Krutmann). ..

    Transfection:

    Article Title: CRISPR/Cas9-mediated editing of XPA in induced pluripotent stem cells: A model for investigating Xeroderma Pigmentosum and NER dysfunction.
    Article Snippet: .. Resource table Unique stem cell line identifier WTSIi018-B-30 Alternative name(s) of stem cell line DU434 Institution IUF Leibniz Institute for Environmental Medicine Contact information of the reported cell line distributor Jean Krutmann; jean.krutmann@IUFduesseldorf.de Type of cell line iPSC Origin Human Additional origin info (applicable for human ESC or iPSC) Age: 55–59 Sex: male Ethnicity: Caucasian; British Cell Source KOLF2.1J, The Jackson Laboratory https://www.jax.org/jax-mice-and-servic es/ipsc Method of reprogramming Sendai Virus Clonality Monoclonal Evidence of the reprogramming transgene loss (including genomic copy if applicable) PCR The cell culture system used iPSCs cultured on geltrex-coated plates and passaged using Accutase Type of the Genetic Modification Patient-specific point mutation Associated disease Xeroderma Pigmentosum (continued on next column) (continued ) Gene/locus XPA homozygous 9q22.33 exon 3 point mutation NM_000380.4(XPA):c.323G>T (p. Cys108Phe) Method of modification / usercustomisable nuclease (UCN) used, the resource used for design optimisation CRISPR/Cas9 User-customisable nuclease (UCN) delivery method Plasmid transfection All double-stranded DNA genetic material molecules introduced into the cells PX458 (Addgene #48138) Analysis of the nuclease-targeted allele status Illumina Deep Sequencing and homozygosity confirmed through ONT Sequencing Method of the off-target nuclease activity prediction and surveillance In-silico Descriptive name of the transgene Eukaryotic selective agent resistance cassettes (including inducible, gene/ cell type-specific) (continued on next page) * Corresponding authors at: Environmental Adaptation and Cellular Resilience Laboratory, IUF-Leibniz Research Institute for Environmental Medicine, Düsseldorf, Germany (A. Rossi) and Environmentally-Induced Skin Aging Group, IUF-Leibniz Research Institute for Environmental Medicine, Düsseldorf, Germany (J. Krutmann). ..

    Sequencing:

    Article Title: CRISPR/Cas9-mediated editing of XPA in induced pluripotent stem cells: A model for investigating Xeroderma Pigmentosum and NER dysfunction.
    Article Snippet: .. Resource table Unique stem cell line identifier WTSIi018-B-30 Alternative name(s) of stem cell line DU434 Institution IUF Leibniz Institute for Environmental Medicine Contact information of the reported cell line distributor Jean Krutmann; jean.krutmann@IUFduesseldorf.de Type of cell line iPSC Origin Human Additional origin info (applicable for human ESC or iPSC) Age: 55–59 Sex: male Ethnicity: Caucasian; British Cell Source KOLF2.1J, The Jackson Laboratory https://www.jax.org/jax-mice-and-servic es/ipsc Method of reprogramming Sendai Virus Clonality Monoclonal Evidence of the reprogramming transgene loss (including genomic copy if applicable) PCR The cell culture system used iPSCs cultured on geltrex-coated plates and passaged using Accutase Type of the Genetic Modification Patient-specific point mutation Associated disease Xeroderma Pigmentosum (continued on next column) (continued ) Gene/locus XPA homozygous 9q22.33 exon 3 point mutation NM_000380.4(XPA):c.323G>T (p. Cys108Phe) Method of modification / usercustomisable nuclease (UCN) used, the resource used for design optimisation CRISPR/Cas9 User-customisable nuclease (UCN) delivery method Plasmid transfection All double-stranded DNA genetic material molecules introduced into the cells PX458 (Addgene #48138) Analysis of the nuclease-targeted allele status Illumina Deep Sequencing and homozygosity confirmed through ONT Sequencing Method of the off-target nuclease activity prediction and surveillance In-silico Descriptive name of the transgene Eukaryotic selective agent resistance cassettes (including inducible, gene/ cell type-specific) (continued on next page) * Corresponding authors at: Environmental Adaptation and Cellular Resilience Laboratory, IUF-Leibniz Research Institute for Environmental Medicine, Düsseldorf, Germany (A. Rossi) and Environmentally-Induced Skin Aging Group, IUF-Leibniz Research Institute for Environmental Medicine, Düsseldorf, Germany (J. Krutmann). ..

    Activity Assay:

    Article Title: CRISPR/Cas9-mediated editing of XPA in induced pluripotent stem cells: A model for investigating Xeroderma Pigmentosum and NER dysfunction.
    Article Snippet: .. Resource table Unique stem cell line identifier WTSIi018-B-30 Alternative name(s) of stem cell line DU434 Institution IUF Leibniz Institute for Environmental Medicine Contact information of the reported cell line distributor Jean Krutmann; jean.krutmann@IUFduesseldorf.de Type of cell line iPSC Origin Human Additional origin info (applicable for human ESC or iPSC) Age: 55–59 Sex: male Ethnicity: Caucasian; British Cell Source KOLF2.1J, The Jackson Laboratory https://www.jax.org/jax-mice-and-servic es/ipsc Method of reprogramming Sendai Virus Clonality Monoclonal Evidence of the reprogramming transgene loss (including genomic copy if applicable) PCR The cell culture system used iPSCs cultured on geltrex-coated plates and passaged using Accutase Type of the Genetic Modification Patient-specific point mutation Associated disease Xeroderma Pigmentosum (continued on next column) (continued ) Gene/locus XPA homozygous 9q22.33 exon 3 point mutation NM_000380.4(XPA):c.323G>T (p. Cys108Phe) Method of modification / usercustomisable nuclease (UCN) used, the resource used for design optimisation CRISPR/Cas9 User-customisable nuclease (UCN) delivery method Plasmid transfection All double-stranded DNA genetic material molecules introduced into the cells PX458 (Addgene #48138) Analysis of the nuclease-targeted allele status Illumina Deep Sequencing and homozygosity confirmed through ONT Sequencing Method of the off-target nuclease activity prediction and surveillance In-silico Descriptive name of the transgene Eukaryotic selective agent resistance cassettes (including inducible, gene/ cell type-specific) (continued on next page) * Corresponding authors at: Environmental Adaptation and Cellular Resilience Laboratory, IUF-Leibniz Research Institute for Environmental Medicine, Düsseldorf, Germany (A. Rossi) and Environmentally-Induced Skin Aging Group, IUF-Leibniz Research Institute for Environmental Medicine, Düsseldorf, Germany (J. Krutmann). ..



    Similar Products

    86
    Jackson Laboratory cell line ipsc origin human additional origin info
    Cell Line Ipsc Origin Human Additional Origin Info, supplied by Jackson Laboratory, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/cell+line+ipsc+origin+human+additional+origin+info/ipsc+line/pm41265249-13-35-59
    Average 86 stars, based on 1 article reviews
    cell line ipsc origin human additional origin info - by Bioz Stars, 2026-10
    86/100 stars
      Buy from Supplier

    Image Search Results